Spontaneous Intramuscular Hematomas in Patients with Severe COVID-19 (Case Report)
https://doi.org/10.15360/1813-9779-2022-1-23-30
Abstract
Aim of the study. To evaluate the risk factors for the occurrence of intramuscular hematomas in patients with severe coronavirus infection receiving anticoagulant therapy.
Materials and methods. Intramuscular hematomas in five patients with severe COVID-19 disease are reported in the paper. The criteria for selecting patients for the study included respiratory distress requiring oxygen, radiographic signs of severe pneumonia, anticoagulant therapy using low molecular weight heparin (LMWH), and spontaneous intramuscular hematoma. Clinical manifestations, blood coagulation results, conservative and surgical management were analyzed.
Results. Standard regimen anticoagulation therapy in patients with coronavirus infection requires vigilance because of a risk of development of hemorrhagic complications.
Сonclusion. When assessing a patient with hematomas, an emphasis should be given to examination of patients and changes in hemoglobin and hematocrit levels. Best strategy of anticoagulant therapy for patients with coronavirus infection and high risk of VTE, as well as optimal laboratory monitoring during LMWH administration are yet to be explored.
About the Authors
N. A. LestevaRussian Federation
2 Akkuratova Str., 197341 St. Petersburg
G. Yu. Rybakov
Russian Federation
2 Akkuratova Str., 197341 St. Petersburg
I. N. Danilov
Russian Federation
2 Akkuratova Str., 197341 St. Petersburg
A. A. Kovalev
Russian Federation
2 Akkuratova Str., 197341 St. Petersburg
A. N. Kondratyev
Russian Federation
2 Akkuratova Str., 197341 St. Petersburg
References
1. Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18 (4): 844–847. DOI: 10.1111/jth.14768.
2. Some aspects of treatment of patients with severe coronavirus infection COVID-19: a guideline for doctors, ed. Professor A.N. Kondratiev. St. Petersburg: Association of Anesthesiologists — resuscitators of the North-West. 2021. 132 p. Chapter IV «Hemostasis system, thrombosis and bleeding in COVID-19» Vavilova T.V., Vlasov V.S., Serafimov S.V., Rudaev L.Ya. pp. 75-98 [In Russ.].
3. Interim guidelines «Prevention, diagnosis and treatment of new coronavirus infection (COVID-19)» Version 9 (10/26/2020). Ministry of Health of the Russian Federation [In Russ.].
4. Barnes G.D., Burnett A., Allen A., Blumenstein M., Clark N.P., Cuker A., Dager W.E., Deitelzweig S.D., Ellsworth S., Garcia D., Kaatz S., Minichiello T. Thromboembolism and anticoagulant therapy during the COVID 19 pandemic: interim clinical guidance from the anticoagulation forum. Journal of Thrombosis and Thrombolysis. 2020; 50: 72–81. DOI: 10.1007/s11239-020-02138-z.
5. Kraynyukov P.E., Demyanenko A.V., Skorobogatov V.M., Efremov K.N., Kim E.A., Efremova A.A. Experience in the treatment of hemorrhagic complications in a patient with a new coronavirus infection on the background of anticoagulant therapy. Voenno-meditsinskij zhurnal. 2021; 342 (5): 75–78. DOI: 10.17816/RMMJ82621.
6. Bargellini I., Cervelli R., Lunardi A., Scandiffio R., Daviddi F., Giorgi L., Cicorelli A., Crocetti L., Cioni R. Spontaneous Bleedings in COVID-19 Patients: An Emerging Complication. Cardiovasc Intervent Radiol. 2020; 43 (7): 1095–1096. DOI: 10.1007/s00270-020-02507-4.
7. Rogani S., Calsolaro V., Franchi R., Calabrese A.M., Okoye C., Monzani F. Spontaneous muscle hematoma in older patients with COVID-19: two case reports and literature review. BMC Geriatr. 2020; 20 (1): 539. DOI: 10.1186/s12877-020-01963-4. PMID: 33353545; PMCID: PMC7755066.
8. Vergori A., Pianura E., Lorenzini P., D'Abramo A., Di Stefano F., Grisetti S., Vita S., Pinnetti C., Donno D.R., Marini M.C.,Nicastri E., Ianniello S., Antinori A., ReCOVeRI Study Group. Spontaneous ilio-psoas haematomas (IPHs): a warning for COVID-19 inpatients. Annals of Medicine. 2021; 53 (1): 295–301. DOI: 10.1080/07853890.2021.1875498.
9. Liu S., Mei C., Zou H., Chang X., Ye Z. Iliopsoas hematoma associated with low-molecular-weight heparin use: A case report. SAGE Open Med Case Rep. 2020; 8: 2050313X20931680. DOI: 10.1177/2050313X20931680. PMID: 32587696; PMCID: PMC7294477.
10. Abate V., Casoria A., Rendina D., Muscariello R., Nuzzo V., Vargas M., Servillo G., Venetucci P., Conca P., Tufano A., Galletti F., Di Minno G. Spontaneous Muscle Hematoma in Patients with COVID-19: A Systematic Literature Review with Description of an Additional Case Series. Semin Thromb Hemost. 2022; 48 (1): 100–108. PMID: 34388842 DOI: 10.1055/s-0041-1732370.
11. Posthuma A.G., Hogervorst M., van Munster B.C. Psoas hematoma in the elderly patient, a diagnostic challenge, a case report. International journal of surgery case reports. 2020; 73: 187–189. DOI: 10.1016/j.ijscr.2020.07.003.
12. Tang N.,| Bai H., Chen X., Gong J., Li D., Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020; 18: 1094–1099. DOI: 10.1111/jth.14817.
13. Nematihonar B., Qaderi S., Shah J., Bagherpour J.Z. Spontaneous giant rectus sheath hematoma in patients with COVID-19: two case reports and literature review. Int J Emerg Med. 2021; 14 (1): 40. DOI: 10.1186/s12245-021-00366-5. PMID: 34301186; PMCID: PMC8300980.
14. Koklu H., Oge Koklu N., Aksoy Khurami F., Duman E., Meral A. Therapy-Related Spontaneous Pectoral Muscle Hematoma: A Case Report and Review of the Literature. J Am Geriatr Soc. 2016; 64 (5): 1135–1137. DOI: 10.1111/jgs.14098. PMID: 27225366.
15.
Review
For citations:
Lesteva N.A., Rybakov G.Yu., Danilov I.N., Kovalev A.A., Kondratyev A.N. Spontaneous Intramuscular Hematomas in Patients with Severe COVID-19 (Case Report). General Reanimatology. 2022;18(1):23-30. https://doi.org/10.15360/1813-9779-2022-1-23-30